BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34946971)

  • 1.
    Duarte-Pereira S; Fajarda O; Matos S; Luís Oliveira J; Silva RM
    Genes (Basel); 2021 Dec; 12(12):. PubMed ID: 34946971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extensive regulation of nicotinate phosphoribosyltransferase (NAPRT) expression in human tissues and tumors.
    Duarte-Pereira S; Pereira-Castro I; Silva SS; Correia MG; Neto C; da Costa LT; Amorim A; Silva RM
    Oncotarget; 2016 Jan; 7(2):1973-83. PubMed ID: 26675378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular nicotinate phosphoribosyltransferase binds Toll like receptor 4 and mediates inflammation.
    Managò A; Audrito V; Mazzola F; Sorci L; Gaudino F; Gizzi K; Vitale N; Incarnato D; Minazzato G; Ianniello A; Varriale A; D'Auria S; Mengozzi G; Politano G; Oliviero S; Raffaelli N; Deaglio S
    Nat Commun; 2019 Sep; 10(1):4116. PubMed ID: 31511522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Versatile Continuous Fluorometric Enzymatic Assay for Targeting Nicotinate Phosphoribosyltransferase.
    Minazzato G; Marangoni E; Fortunato C; Petrelli R; Cappellacci L; Del Bello F; Sorci L; Gasparrini M; Piacente F; Bruzzone S; Raffaelli N
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36770640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevation of cellular NAD levels by nicotinic acid and involvement of nicotinic acid phosphoribosyltransferase in human cells.
    Hara N; Yamada K; Shibata T; Osago H; Hashimoto T; Tsuchiya M
    J Biol Chem; 2007 Aug; 282(34):24574-82. PubMed ID: 17604275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properly Substituted Benzimidazoles as a New Promising Class of Nicotinate Phosphoribosyltransferase (NAPRT) Modulators.
    Baldassarri C; Giorgioni G; Piergentili A; Quaglia W; Fontana S; Mammoli V; Minazzato G; Marangoni E; Gasparrini M; Sorci L; Raffaelli N; Cappellacci L; Petrelli R; Del Bello F
    Pharmaceuticals (Basel); 2023 Jan; 16(2):. PubMed ID: 37259338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NAD metabolic dependency in cancer is shaped by gene amplification and enhancer remodelling.
    Chowdhry S; Zanca C; Rajkumar U; Koga T; Diao Y; Raviram R; Liu F; Turner K; Yang H; Brunk E; Bi J; Furnari F; Bafna V; Ren B; Mischel PS
    Nature; 2019 May; 569(7757):570-575. PubMed ID: 31019297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of human nicotinate phosphoribosyltransferase: Kinetic studies, structure prediction and functional analysis by site-directed mutagenesis.
    Galassi L; Di Stefano M; Brunetti L; Orsomando G; Amici A; Ruggieri S; Magni G
    Biochimie; 2012 Feb; 94(2):300-9. PubMed ID: 21742010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NAMPT and NAPRT, Key Enzymes in NAD Salvage Synthesis Pathway, Are of Negative Prognostic Value in Colorectal Cancer.
    Li XQ; Lei J; Mao LH; Wang QL; Xu F; Ran T; Zhou ZH; He S
    Front Oncol; 2019; 9():736. PubMed ID: 31448236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of NAPRT Inhibitors with Anti-Cancer Properties by In Silico Drug Discovery.
    Ghanem MS; Caffa I; Del Rio A; Franco J; Parenti MD; Monacelli F; Cea M; Khalifa A; Nahimana A; Duchosal MA; Ravera S; Bertola N; Bruzzone S; Nencioni A; Piacente F
    Pharmaceuticals (Basel); 2022 Jul; 15(7):. PubMed ID: 35890147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotinic Acid Phosphoribosyltransferase Regulates Cancer Cell Metabolism, Susceptibility to NAMPT Inhibitors, and DNA Repair.
    Piacente F; Caffa I; Ravera S; Sociali G; Passalacqua M; Vellone VG; Becherini P; Reverberi D; Monacelli F; Ballestrero A; Odetti P; Cagnetta A; Cea M; Nahimana A; Duchosal M; Bruzzone S; Nencioni A
    Cancer Res; 2017 Jul; 77(14):3857-3869. PubMed ID: 28507103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of NAD metabolism in neuronal differentiation.
    Neves D; Goodfellow BJ; Vieira SI; Silva RM
    Neurochem Int; 2022 Oct; 159():105402. PubMed ID: 35843422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression patterns of nicotinamide phosphoribosyltransferase and nicotinic acid phosphoribosyltransferase in human malignant lymphomas.
    Olesen UH; Hastrup N; Sehested M
    APMIS; 2011 Apr; 119(4-5):296-303. PubMed ID: 21492230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NAMPT and NAPRT: Two Metabolic Enzymes With Key Roles in Inflammation.
    Audrito V; Messana VG; Deaglio S
    Front Oncol; 2020; 10():358. PubMed ID: 32266141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective Cytotoxicity of the NAMPT Inhibitor FK866 Toward Gastric Cancer Cells With Markers of the Epithelial-Mesenchymal Transition, Due to Loss of NAPRT.
    Lee J; Kim H; Lee JE; Shin SJ; Oh S; Kwon G; Kim H; Choi YY; White MA; Paik S; Cheong JH; Kim HS
    Gastroenterology; 2018 Sep; 155(3):799-814.e13. PubMed ID: 29775598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel NAPRT specific antibody identifies small cell lung cancer and neuronal cancers as promising clinical indications for a NAMPT inhibitor/niacin co-administration strategy.
    Cole J; Guiot MC; Gravel M; Bernier C; Shore GC; Roulston A
    Oncotarget; 2017 Sep; 8(44):77846-77859. PubMed ID: 29100430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the NAD Salvage Synthesis Pathway as a Novel Therapeutic Strategy for Osteosarcomas with Low NAPRT Expression.
    Franceschini N; Oosting J; Tamsma M; Niessen B; Bruijn IB; van den Akker B; Kruisselbrink AB; Palubeckaitė I; Bovée JVMG; Cleton-Jansen AM
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-Based Identification and Biological Characterization of New NAPRT Inhibitors.
    Franco J; Piacente F; Walter M; Fratta S; Ghanem M; Benzi A; Caffa I; Kurkin AV; Altieri A; Herr P; Martínez-Bailén M; Robina I; Bruzzone S; Nencioni A; Del Rio A
    Pharmaceuticals (Basel); 2022 Jul; 15(7):. PubMed ID: 35890155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TF-RBP-AS Triplet Analysis Reveals the Mechanisms of Aberrant Alternative Splicing Events in Kidney Cancer: Implications for Their Possible Clinical Use as Prognostic and Therapeutic Biomarkers.
    He M; Hu F
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzymology of extracellular NAD metabolism.
    Gasparrini M; Sorci L; Raffaelli N
    Cell Mol Life Sci; 2021 Apr; 78(7):3317-3331. PubMed ID: 33755743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.